Scienture Holdings PE Ratio 2013-2024 | SCNX
Current and historical p/e ratio for Scienture Holdings (SCNX) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Scienture Holdings PE ratio as of October 04, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Scienture Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-10-03 | 7.04 | inf | |
| 2024-06-30 | 10.14 | 0 | 0.00 |
| 2024-03-31 | 9.29 | 0 | 0.00 |
| 2023-12-31 | 2.56 | 0 | 0.00 |
| 2023-09-30 | 3.47 | 0 | 0.00 |
| 2023-03-31 | 2.18 | 0 | 0.00 |
| 2022-12-31 | 2.98 | 0 | 0.00 |
| 2022-09-30 | 8.36 | 0 | 0.00 |
| 2022-06-30 | 11.98 | 0 | 0.00 |
| 2022-03-31 | 20.48 | 0 | 0.00 |
| 2021-12-31 | 17.45 | 0 | 0.00 |
| 2023-06-30 | 6.43 | 0 | 0.00 |
| 2021-09-30 | 36.41 | 0 | 0.00 |
| 2021-06-30 | 32.68 | 0 | 0.00 |
| 2021-03-31 | 38.75 | 0 | 0.00 |
| 2020-12-31 | 39.12 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.012B | $0.008B |
| TRxADE HEALTH INC. is a health services IT company focused on digitalizing the retail pharmacy experience. TRxADE HEALTH INC., formerly known as TRxADE Group Inc., is based in TAMPA, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $114.104B | 13.91 |
| Cencora (COR) | United States | $43.339B | 16.56 |
| DiDi Global (DIDIY) | China | $24.254B | 0.00 |
| ICON (ICLR) | Ireland | $24.216B | 21.76 |
| Avantor (AVTR) | United States | $17.207B | 26.09 |
| Natera (NTRA) | United States | $16.059B | 0.00 |
| Revvity (RVTY) | United States | $15.289B | 26.77 |
| BioMerieux (BMXMF) | France | $13.891B | 0.00 |
| Viatris (VTRS) | United States | $13.833B | 4.21 |
| CochLear (CHEOY) | Australia | $13.111B | 0.00 |
| Solventum (SOLV) | United States | $11.699B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.635B | 32.27 |
| Charles River Laboratories (CRL) | United States | $9.848B | 18.61 |
| Sonic Healthcare (SKHHY) | Australia | $8.945B | 0.00 |
| Doximity (DOCS) | United States | $8.138B | 51.56 |
| HealthEquity (HQY) | United States | $7.256B | 39.38 |
| Bausch + Lomb (BLCO) | Canada | $6.689B | 28.79 |
| PACS (PACS) | United States | $5.867B | 0.00 |
| Life Times (LTH) | United States | $4.961B | 41.47 |
| Organon (OGN) | United States | $4.709B | 4.79 |
| Sotera Health (SHC) | United States | $4.475B | 22.57 |
| Surgery Partners (SGRY) | United States | $3.961B | 43.89 |
| GoodRx Holdings (GDRX) | United States | $2.690B | 101.29 |
| Concentras Parent (CON) | United States | $2.655B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.568B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $2.531B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.089B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| Premier (PINC) | United States | $1.923B | 8.64 |
| CareDx (CDNA) | United States | $1.630B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.548B | 0.00 |
| Progyny (PGNY) | United States | $1.472B | 25.87 |
| AMN Healthcare Services Inc (AMN) | United States | $1.456B | 7.31 |
| GeneDx Holdings (WGS) | United States | $1.342B | 0.00 |
| Agilon Health (AGL) | United States | $1.321B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.264B | 0.00 | |
| QDM (QDMI) | Hong Kong, SAR China | $1.125B | 29.47 |
| Pediatrix Medical (MD) | United States | $1.042B | 11.34 |
| Embecta (EMBC) | United States | $0.780B | 5.20 |
| InnovAge Holding (INNV) | United States | $0.746B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.529B | 0.00 |
| Sharecare (SHCR) | United States | $0.528B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.455B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.425B | 0.00 |
| Enhabit (EHAB) | United States | $0.376B | 32.52 |
| DocGo (DCGO) | United States | $0.343B | 12.88 |
| Biodesix (BDSX) | United States | $0.245B | 0.00 |
| ModivCare (MODV) | United States | $0.241B | 7.67 |
| Sera Prognostics (SERA) | United States | $0.241B | 0.00 |
| LifeMD (LFMD) | United States | $0.208B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.174B | 0.00 |
| MultiPlan (MPLN) | United States | $0.145B | 0.00 |
| So-Young (SY) | China | $0.125B | 30.25 |
| Nutex Health (NUTX) | United States | $0.111B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 1.72 |
| SBC Medicals (SBC) | United States | $0.042B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.038B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.024B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.018B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |